Home > Healthcare > Medical Devices > Diagnostic Devices > Liquid Biopsy Market

Liquid Biopsy Market Size

Report ID: GMI3775
Published Date: Nov 2021
Report Format: PDF

Download Free Sample

Liquid Biopsy Market Size

Liquid Biopsy Market size exceeded USD 1.2 billion in 2020 and is anticipated to grow at a CAGR of over 29.7% between 2021 and 2027. Growing awareness regarding causes and diagnosis of cancer with several awareness campaigns will contribute to the demand for liquid biopsy in the coming years.

Liquid Biopsy Market Overview

To get key market trends

Download Free Sample

Liquid Biopsy Market Report Attributes
Report Attribute	Details
Base Year:	2020
Liquid Biopsy Market Size in 2020:	1.6 Billion (USD)
Forecast Period:	2021 to 2027
Forecast Period 2021 to 2027 CAGR:	29.7%
2027 Value Projection:	10.2 Billion (USD)
Historical Data for:	2016 to 2020
No. of Pages:	130
Tables, Charts & Figures:	170
Segments covered:	Product, Application, Distribution Channel and Region
Growth Drivers:	Continuous technological advancements in cancer diagnostics Increasing preference for non-invasive disease diagnosis Growing prevalence of cancer worldwide Rising awareness regarding early disease diagnosis
Pitfalls & Challenges:	Stringent regulatory framework Lack of skilled professionals

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Market size of liquid biopsy surpassed USD 1.2 billion in 2020 and is expected to expand at a CAGR of 29.7% from 2021 to 2027 with increasing awareness regarding the causes and diagnosis of cancer.

The kits & reagents accounted for over 50% of the revenue share in 2020 and will grow with soaring adoption of liquid biopsy in research institutes and reference laboratories.

The lung cancer is poised to exhibit a growth rate of 29.7% up to 2027 owing to the growing adoption of unhealthy lifestyle, comprising tobacco consumption and smoking, and a subsequent increase in the incidence rate.

North America market size recorded 31% of the global industry revenue in 2020 and will rise with the availability of highly advanced infrastructure and faster adoption of advanced methods.

Major players across the industry comprise Guardant Health, Inc., F. Hoffmann-La Roche Ltd., Lucence Health Inc., Genetics, Inc., BIOCEPT, Inc., and others.